{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T01:26:44Z","timestamp":1787794004144,"version":"build-2784847793"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2013,8,30]],"date-time":"2013-08-30T00:00:00Z","timestamp":1377820800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s00415-013-7084-y","type":"journal-article","created":{"date-parts":[[2013,8,29]],"date-time":"2013-08-29T00:41:08Z","timestamp":1377736868000},"page":"2653-2655","source":"Crossref","is-referenced-by-count":19,"title":["A TREX1 mutation causing cerebral vasculopathy in a patient with familial chilblain lupus"],"prefix":"10.1007","volume":"260","author":[{"given":"Kazuo","family":"Yamashiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanzhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michitaka","family":"Mikasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobutaka","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,30]]},"reference":[{"key":"7084_CR1","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1365-2133.1978.tb01935.x","volume":"98","author":"LG Millard","year":"1978","unstructured":"Millard LG, Rowell NR (1978) Chilblain lupus erythematosus (Hutchinson). A clinical and laboratory study of 17 patients. Br J Dermatol 98:497\u2013506","journal-title":"Br J Dermatol"},{"key":"7084_CR2","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1086\/507848","volume":"79","author":"MA Lee-Kirsch","year":"2006","unstructured":"Lee-Kirsch MA, Gong M, Schulz H et al (2006) Familial chilblain lupus, a monogenic form of cutaneous lupus erythematosus, maps to chromosome 3p. Am J Hum Genet 79:731\u2013737","journal-title":"Am J Hum Genet"},{"key":"7084_CR3","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00109-007-0199-9","volume":"85","author":"MA Lee-Kirsch","year":"2007","unstructured":"Lee-Kirsch MA, Chowdhury D, Harvey S et al (2007) A mutation in TREX1 that impairs susceptibility to granzyme A-mediated cell death underlies familial chilblain lupus. J Mol Med (Berl) 85:531\u2013537","journal-title":"J Mol Med (Berl)"},{"key":"7084_CR4","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1086\/513443","volume":"80","author":"G Rice","year":"2007","unstructured":"Rice G, Newman WG, Dean J et al (2007) Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutieres syndrome. Am J Hum Genet 80:811\u2013815","journal-title":"Am J Hum Genet"},{"key":"7084_CR5","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1038\/jid.2012.210","volume":"132","author":"K Sugiura","year":"2012","unstructured":"Sugiura K, Takeichi T, Kono M et al (2012) Severe chilblain lupus is associated with heterozygous missense mutations of catalytic amino acids or their adjacent mutations in the exonuclease domains of 3\u2032-repair exonuclease 1. J Invest Dermatol 132:2855\u20132857","journal-title":"J Invest Dermatol"},{"key":"7084_CR6","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1365-2133.2012.10813.x","volume":"167","author":"V Tungler","year":"2012","unstructured":"Tungler V, Silver RM, Walkenhorst H et al (2012) Inherited or de novo mutation affecting aspartate 18 of TREX1 results in either familial chilblain lupus or Aicardi-Goutieres syndrome. Br J Dermatol 167:212\u2013214","journal-title":"Br J Dermatol"},{"key":"7084_CR7","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/rheumatology\/kes181","volume":"52","author":"J Abe","year":"2013","unstructured":"Abe J, Izawa K, Nishikomori R et al (2013) Heterozygous TREX1 p.Asp18Asn mutation can cause variable neurological symptoms in a family with Aicardi-Goutieres syndrome\/familial chilblain lupus. Rheumatology (Oxford) 52:406\u2013408","journal-title":"Rheumatology (Oxford)"},{"key":"7084_CR8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/ajmg.a.33778","volume":"155A","author":"JC Ravenscroft","year":"2011","unstructured":"Ravenscroft JC, Suri M, Rice GI et al (2011) Autosomal dominant inheritance of a heterozygous mutation in SAMHD1 causing familial chilblain lupus. Am J Med Genet 155A:235\u2013237","journal-title":"Am J Med Genet"},{"key":"7084_CR9","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/ng2091","volume":"39","author":"MA Lee-Kirsch","year":"2007","unstructured":"Lee-Kirsch MA, Gong M, Chowdhury D et al (2007) Mutations in the gene encoding the 3\u2032-5\u2032 DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat Genet 39:1065\u20131067","journal-title":"Nat Genet"},{"key":"7084_CR10","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/ng1845","volume":"38","author":"YJ Crow","year":"2006","unstructured":"Crow YJ, Hayward BE, Parmar R et al (2006) Mutations in the gene encoding the 3\u2032-5\u2032 DNA exonuclease TREX1 cause Aicardi-Goutieres syndrome at the AGS1 locus. Nat Genet 38:917\u2013920","journal-title":"Nat Genet"},{"key":"7084_CR11","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/ng2082","volume":"39","author":"A Richards","year":"2007","unstructured":"Richards A, van den Maagdenberg AM, Jen JC et al (2007) C-terminal truncations in human 3\u2032-5\u2032 DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy. Nat Genet 39:1068\u20131070","journal-title":"Nat Genet"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-013-7084-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-013-7084-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-013-7084-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T15:23:16Z","timestamp":1559056996000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-013-7084-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,30]]},"references-count":11,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["7084"],"URL":"https:\/\/doi.org\/10.1007\/s00415-013-7084-y","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,30]]}}}